Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
International Journal of Biological Macromolecules|February 19, 2025
The use of aptamers as therapeutic inhibitors and biosensors of TNF-alphaHossein Samiei Abianeh, Prashant Kesharwani, Amirhossein SahebkarScientific Reports|June 25, 2026
PLGA-entrapped recombinant r63 chimeric protein induces mucosal immunity against adherence and toxicity of Vibrio choleraeHossein Samiei-Abianeh, Shahram Nazarian, Mohammad Behrozie, et al.Bioimpacts : BI|April 21, 2025
Recombinant receptor-binding motif of spike COVID-19 vaccine candidate induces SARS-CoV-2 neutralizing antibody responseHossein Samiei-Abianeh, Shahram Nazarian, Emad Kordbacheh, et al.Iranian Journal of Immunology : IJI|September 30, 2025
Bioinformatic Analysis and Recombinant Expression of the Stonustoxin β-Subunit for Polyclonal Antibody DevelopmentMohammadreza Rahmani, Shahram Nazarian, Hossein Samiei-Abianeh, et al.Journal of Immunological Methods|January 11, 2026
PLGA-based nanovaccine delivering chimeric IpaD-StxB protein induces robust immune response against Shigella infectionAyoub Fazeli, Hosein Honari, Davoud Sadeghi, et al.Current Protein & Peptide Science|October 21, 2025
Solid-Phase Synthesized Imunofan Confers Clinically Relevant Protection using a Chimeric Protein Vaccine Candidate Against E. coli O157:H7 in BALB/c MiceAli Mozaffari Mansourabad, Hossein Samiei-Abianeh, Yousof Tarverdizadeh, et al.Molecular Immunology|July 25, 2024
Evaluation of the prophylactic effect of egg yolk antibody (IgY) produced against the recombinant protein containing IpaD, IpaB, StxB, and VirG proteins from ShigellaAlireza Felegary, Shahram Nazarian, Mojtaba Zafarmand-Samarin, et al.Journal of Immunological Methods|June 29, 2023
PLGA nanoparticles containing Intimin-Flagellin fusion protein for E. coli O157:H7 nano-vaccineHossein Samiei Abianeh, Shahram Nazarian, Davoud Sadeghi, et al.Heliyon|November 11, 2024
Therapeutic efficacy of SipD/LptD-specific IgY entrapped in alginate nanoparticles against Salmonella Typhimurium infectionMojtaba Zafarmand-Samarin, Shahram Nazarian, Seyed Mojtaba Aghaie, et al.Avicenna Journal of Medical Biotechnology|December 12, 2022
Antibodies Produced Toward Recombinant RBD and Nucleocapsid Neutralize SARS-COV-2Amir Rezaei, Shahram Nazarian, Hossein Samiei Abianeh, et al.Pageof 2